Infected tumor prostheses

Orthopedics

Volumn 34, Issue 12, 2011, Pages 991-998

  Mavrogenis, Andreas F ^a   Papagelopoulos, Panayiotis J ^b   Coll Mesa, Luis ^a   Pala, Elisa ^a   Guerra, Giovanni ^a   Ruggieri, Pietro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SILVER; TITANIUM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BIOFILM; BONE RADIOGRAPHY; CANCER SURVIVAL; CLINICAL FEATURE; DEBRIDEMENT; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS ARTHRITIS; MATERIAL COATING; METAL IMPLANTATION; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PATIENT SATISFACTION; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; REOPERATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURGICAL RISK; SURVIVAL TIME;

BIOFILMS; BONE NEOPLASMS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIMB SALVAGE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RISK FACTORS;

EID: 83655191500     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20111021-24     Document Type: Review

References (78)

1. Eilber FR, Eckhardt J, Morton DL. Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer. 1984; 54(11 Suppl):2695-2701. (Pubitemid 15187409)
2. Turcotte R. Endoprosthetic replacements for bone tumors: review of the most recent literature. Curr Opin Orthop. 2007; 18(6):572-578. (Pubitemid 350293723)
3. DiCaprio MR, Friedlaender GE. Malignant bone tumors: limb sparing versus amputation. J Am Acad Orthop Surg. 2003; 11(1):25-37.
4. Jeys LM, Kulkarni A, Grimer RJ, Carter SR, Tillman RM, Abudu A. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am. 2008; 90(6):1265-1271. (Pubitemid 351778134)
5. Bosquet M, Burssens A, Mulier JC. Long term follow-up results of a femoral megaprosthesis. Arch Orthop Trauma Surg. 1980; 97(4):299-304.
6. Gaur AH, Liu T, Knapp KM, et al. Infections in children and young adults with bone malignancies undergoing limb-sparing surgery. Cancer. 2005; 104(3):602-610. (Pubitemid 41022819)
7. Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br. 2006; 88(6):790-795. (Pubitemid 43971146)
8. Gitelis S, Yergler J, Sawlani N, Schiff A, Shott S. Short and long term failure of the modular oncology knee prosthesis. Orthopedics. 2008; 31(4):362.
9. Shehadeh A, Noveau J, Malawer M, Henshaw R. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop Relat Res. 2010; 468(11):2885-2895.
10. Ilyas I, Kurar A, Moreau PG, Younge DA. Modular megaprosthesis for distal femoral tumors. Int Orthop. 2001; 25(6):375-377. (Pubitemid 34016811)
11. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large- segment replacements in the treatment of high grade bone sarcomas. J Bone Joint Surg Am. 1995; 77(8):1154-1165.
12. Plotz W, Rechl H, Burgkart R, et al. Limb salvage with tumor endoprostheses for malignant tumors of the knee. Clin Orthop Relat Res. 2002; (405):207-215. (Pubitemid 36008264)
13. Wirganowicz PC, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM. Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res. 1999; (358):64-74. (Pubitemid 29066075)
14. Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br. 1994; 76(2):178-186. (Pubitemid 24083228)
15. Krajbich JI. Modified Van Nes rotationplasty in the treatment of malignant neoplasms in the lower extremities of children. Clin Orthop Relat Res. 1991; (262):74-77.
16. Duffy GP, Wood MB, Rock MG, Sim FH. Vascularized free fibular transfer combined with autografting for the management of fracture nonunions associated with radiation therapy. J Bone Joint Surg Am. 2000; 82(4):544-554. (Pubitemid 30202801)
17. Dick HM, Strauch RJ. Infection of massive bone allografts. Clin Orthop Relat Res. 1994; (306):46-53. (Pubitemid 24324933)
18. Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am. 2005; 87(4):842-849. (Pubitemid 40489362)
19. Brigman B, Hornicek FJ, Gebhardt MC, Mankin HJ. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res. 2004; (421):232-239. (Pubitemid 38579747)
20. Jeys L, Grimer R, Carter S, Tillman RM. Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients [published online ahead of print February 8, 2003]. Int Orthop. 2003; 27(3):160-163. (Pubitemid 36828224)
21. Grimer RJ, Belthur M, Chandrasekar C, Carter SR, Tillman RM. Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop Relat Res. 2002; (395):193-203. (Pubitemid 34136672)
22. Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007; 14(10):2887-2895. (Pubitemid 47460646)
23. Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother. 1998; 42(11):3002-3005. (Pubitemid 28501241)
24. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15(2):167-193. (Pubitemid 34303762)
25. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37(6):1771-1776. (Pubitemid 29235221)
26. Trampuz A, Steckelberg JM, Osmon DR, Cockerill FR III, Hanssen AD, Patel R. Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol. 2003; 14(1):1-14. (Pubitemid 36397089)
27. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Bisno AL, Waldvogel FA (Eds). Infections Associated with Indwelling Medical Devices. Washington, DC: American Society for Microbiology; 1994:259-290.
28. Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop Relat Res. 1996; (332):184-189. (Pubitemid 26372868)
29. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am. 1975; 6:991-1003.
30. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA 2nd, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977; 59(7):847-855. (Pubitemid 8218237)
31. Moran E, Byren I, Atkins BL. The diagnosis and management of prosthetic joint infections. J Antimicrob Chemother. 2010; 65 Suppl 3:iii45-iii54.
32. Zimmerli W, Trampuz A, Ochsner P. Prosthetic-joint infections. N Engl J Med. 2004; 351(16):1645-1654.
33. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg Am. 1998; 80:910-922. (Pubitemid 28299712)
34. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998; 27(5):1247-1254. (Pubitemid 29242479)
35. Jeys LM, Luscombe JS, Grimer RJ, Abudu A, Tillman RM, Carter SR. The risks and benefits of radiotherapy with massive endoprosthetic replacement. J Bone Joint Surg Br. 2007; 89(10):1352-1355. (Pubitemid 350157319)
36. Hardes J, Gebert C, Schwappach A, et al. Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006; 126(5):289-296. (Pubitemid 43941784)
37. Funovics PT, HipflC, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M. Management of septic complications following modular endoprosthetic reconstruction of the proximal femur [published online ahead of print Aug 28 2010]. Int Orthop. 2011; 35(10):1437-1444. doi: 10.1007/s00264-010-1054-0.
38. Lee SH, Oh JH, Lee KS, Yoo KH, Kim HS. Infection after prosthetic reconstruction in limb salvage surgery. Int Orthop. 2002; 26(3):179-184. (Pubitemid 36061627)
39. Bickels J, Wittig J, Kollender Y, et al. Distal femur resection with endoprosthetic reconstruction: a long-term follow-up study. Clin Orthop Relat Res. 2002; (400):225-235. (Pubitemid 34734474)
40. Grimer RJ, Carter SR, Tillman RM, et al. Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br. 1999; 81(3):488-494. (Pubitemid 29245908)
41. Mayilvahanan N, Paraskumar M, Sivaseelam A, Natarajan S. Custom megaprosthetic replacement for proximal humeral tumours. Int Orthop. 2006; 30(3):158-162. (Pubitemid 44324069)
42. Sharma S, Turcotte RE, Isler MH, Wong C. Experience with cemented large segment endoprostheses for tumors. Clin Orthop Relat Res. 2007; 459:54-59. (Pubitemid 46878194)
43. Crockarell JR Jr, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am. 1998; 80:1306-1313. (Pubitemid 28443354)
44. Ayoub KS, Fiorenza F, Grimer RJ, Tillman RM, Carter SR. Extensible endoprostheses of the humerus after resection of bone tumours. J Bone Joint Surg Br. 1999; 81(3):495-500. (Pubitemid 29245909)
45. Grimer RJ, Belthur M, Carter SR, Tillman RM, Cool P. Extendible replacements of the proximal tibia for bone tumours. J Bone Joint Surg Br. 2000; 82(2):255-260. (Pubitemid 30167085)
46. Neel MD, Wilkins RM, Rao BN, Kelly CM. Early multicenter experience with a noninvasive expandable prosthesis. Clin Orthop Relat Res. 2003; (415):72-81. (Pubitemid 37336520)
47. Mulamba L, Ferrant A, Leners N, de Nayer P, Rombouts JJ, Vincent A. Indium-111 leucocyte scanning in the evaluation of painful hip arthroplasty. Acta Orthop Scand. 1983; 54(5):695-697. (Pubitemid 13005304)
48. Love C, Marwin SE, Tomas MB, et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection fluorine-18 FDG and indium-111-labeled leukocyte/technetium-99m-sulfur colloid marrow imaging. J Nucl Med. 2004; 45(11):1864-1871. (Pubitemid 47618444)
49. Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics. 2006; 26(3):859-70. (Pubitemid 43824981)
50. Palestro CJ, Torres MA. Radionuclide diagnosis of orthopedic infections. Semin Nucl Med. 1997; 27(4):334-345.
51. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics. 2001; 21(5):1229-1238. (Pubitemid 33707233)
52. Araki N, Myoui A, Kuratsu S, et al. Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop Relat Res. 1999; (368):196-206. (Pubitemid 29533995)
53. Chan YS, Ueng SW, Wang CJ, Lee SS, Chen CY, Shin CH. Antibiotic- impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small infected tibial defects: a comparison study. J Trauma. 2000; 48(2):246-255. (Pubitemid 30112074)
54. Bohm P, Springfield R, Springer H. Reimplantation of autoclaved bone segments in musculoskeletal tumor surgery. Clinical experience in 9 patients for 1.1-8.4 years and review of the literature. Arch Orthop Trauma Surg. 1998; 118(1-2):57-65. (Pubitemid 29037647)
55. Dixon P, Parish E, Cross M. Arthroscopic debridement in the treatment of the infected total knee replacement. J Bone Joint Surg Br. 2004; 86(1):39-42. (Pubitemid 38128703)
56. Marculescu C, Berbari E, Hanssen A, et al. Outcome of prosthetic joint infections treated with debridement and retention of components [published online ahead of print January 5, 2006]. Clin Infect Dis. 2006; 42(4):471-478. (Pubitemid 43202518)
57. Flint MN, Griffin AM, Bell RS, Wunder JS, Ferguson PC. Two-stage revision of infected uncemented lower extremity tumor endoprostheses. J Arthroplasty. 2007; 22(6):859-865. (Pubitemid 47361662)
58. Holzer G, Windhager R, Kotz R. One-stage revision surgery for infected megaprostheses. J Bone Joint Surg Am. 1998; 79(1):31-35.
59. Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am. 1995; 77(10):1576-1588.
60. Stockley I, Mockford B, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008; 90(2):145-148. (Pubitemid 351303337)
61. Cui Q, Mihalko W, Shields J, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007; 89(4):871-882. (Pubitemid 46564296)
62. Bejon P, Berendt A, Atkins B, et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology [published online ahead of print January 6, 2010]. J Antimicrob Chemother. 2010; 65(3):569-575.
63. Ure KJ, Amstutz HC, Masser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. J Bone Joint Surg Am. 1998; 80(7):961-968. (Pubitemid 28355666)
64. Younger ASE, Duncan CP, Masri BA. Treatment of infection associated with segmental bone loss in the proximal part of the femur in two stages with use of an antibiotics-loaded interval prosthesis. J Bone Joint Surg Am. 1998; 80(1):60-69. (Pubitemid 28087302)
65. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection evidence for a local granulocyte defect. J Clin Invest. 1984; 73(4):1191-1200. (Pubitemid 14132850)
66. Frommelt L. Principles of systemic antimicrobial therapy in foreign material associated infection in bone tissue, with special focus on periprosthetic infection. Injury. 2006; 37(Suppl 2):S87-S94.
67. von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs. 2005; 65(2):179-214. (Pubitemid 40139382)
68. Howie DW, Rogers SD, McGee MA, Haynes DR. Biologic effects of cobalt chrome in cell and animal models. Clin Orthop Relat Res. 1996; (329 Suppl):S217-S232.
69. Shanbhag A, Yang J, Lilien J, Black J. Decreased neutrophil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in vitro. J Biomed Mater Res. 1992; 26(2):185-195.
70. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am. 1985; 67(2):264-273. (Pubitemid 15167129)
71. Gristina AG, Giridhar G, Gabriel BL, Naylor PT, Myrvik QN. Cell biology and molecular mechanisms in artificial device infections. Int J Artif Organs. 1993; 16(11):755-763.
72. Gosheger G, Goetze C, Hardes J, Joosten U, Winkelmann W, von Eiff C. The influence of the alloy of megaprostheses on infection rate. J Arthroplasty. 2008; 23(6):916-920.
73. Gosheger G, Hardes J, Ahrens H, et al. Silver-coated megaendoprostheses in a rabbit model - an analysis of the infection rate and toxicological side effects. Biomaterials. 2004; 25(24):5547-5556. (Pubitemid 38610194)
74. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol. 1996; 26(3):255-260. (Pubitemid 26197836)
75. Klasen HJ. Historical review of the use of silver in the treatment of burns I. Early uses. Burns. 2000; 26(2):117-130. (Pubitemid 30050604)
76. Olson ME, Harmon BG, Kollef MH. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest. 2002; 121(3):863-870. (Pubitemid 34251456)
77. Bosetti M, Masse A, Tobin E, Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials. 2002; 23(3):887-892. (Pubitemid 33108964)
78. Hardes J, Ahrens H, Gebert C, Streitbuerger A, et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials. 2007; 28(18):2869-2875. (Pubitemid 46482663)